magnesium-pyridoxal-5'-phosphate glutamate has been researched along with Cardiovascular Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aretz, CP; Dinant, GJ; Schuitemaker, GE; van der Pol, GA | 1 |
1 trial(s) available for magnesium-pyridoxal-5'-phosphate glutamate and Cardiovascular Diseases
| Article | Year |
|---|---|
A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical-chemical risk factors of cardiovascular disease in a primary care setting.
Topics: Adult; Aged; Apolipoproteins A; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Female; Glutamine; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Netherlands; Pyridoxal Phosphate; Reference Values | 2001 |